The un-audited standalone financial results along with limited review report for the quarter and nine months ending December 31, 2025, as approved by Board of Directors in their meeting held on Wednesday, 18th March, 2026, has been attached herewith.
Results - Financial Results For December 31, 2025
Filed with BSE · · 12 pages · English
Release
Earlier from Dharti Proteins
- Board Meeting Outcome for Meeting Of Board Of Directors Held On Wednesday, 18Th March, 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Board Meeting Intimation for Approval Of Un-Audited Standalone Financial Results For Quarter And Nine Months Ending December 31, 2025.
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
- Disclosure Under Regulation 29 (1) Of The SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
Later from Dharti Proteins
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Closure of Trading Window
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate: Annexure A
- Outcome Of 3Rd Monitoring Committee Meeting Of Dharti Proteins Limited (Formerly Known As Devika Proteins Limited) Held On 27Th April, 2026
- Reg. 34 (1) Annual Report.
Follow Dharti Proteins into a list and get an email when it puts out news.
Follow Dharti Proteins